Clinical Trials Browser

OTHER × Head and Neck Neoplasms × Radiosurgery × Clear all

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02474368 2025-07-10

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Phase 1 Active not recruiting

21 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03539198 2024-11-14

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Terminated

19 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03511391 2024-01-23

CHEERS

Phase 2 Completed

99 enrolled

DermatologicGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

NCT05259319 2023-10-17

IMMUNOs-SBRT

Phase 1 Unknown

92 enrolled

GenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT02057107 2023-06-05

SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN

Phase 2 Completed

40 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02158234 2023-01-19

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Phase 1 Completed

20 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases

NCT02516969 2022-01-14

Surgery With or Without Adjuvant Stereotactic Body Radiotherapy

Phase NA Completed

7 enrolled 8 charts

Head & Neck

Head and Neck Neoplasms

NCT03402737 2021-02-18

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

Phase NA Terminated

6 enrolled

Head & Neck

Head and Neck Neoplasms

NCT04435938 2020-12-02

SHINE

Phase 2 Unknown

38 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT01344356 2020-04-10

Stereotactic Body Radiotherapy for Head and Neck Tumors

Phase 4 Completed

19 enrolled 10 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT02110992 2019-11-25

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Phase 1 Terminated

7 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00851253 2018-01-17

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Phase NA Completed

12 enrolled 10 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00891904 2016-04-14

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer

Phase NA Terminated

2 enrolled 6 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Clinical Trials

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

CHEERS

IMMUNOs-SBRT

SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Surgery With or Without Adjuvant Stereotactic Body Radiotherapy

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

SHINE

Stereotactic Body Radiotherapy for Head and Neck Tumors

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer